The Menopause Clinic

Condition

Vaginal dryness and painful sex

Vaginal dryness, burning, and pain with sex after menopause are part of genitourinary syndrome of menopause, or GSM — a physical change in the vaginal and urethral tissue caused by falling estrogen. Unlike hot flashes, GSM does not improve on its own and usually gets worse over time. Low-dose vaginal estrogen treats it directly, delivers very little estrogen into the bloodstream, and is the treatment with the strongest evidence.

What women describe

  • Dryness, or a raw or burning feeling, that is there even without sex
  • Pain with penetration, or tearing and bleeding afterward
  • Loss of natural lubrication that lubricants only partly solve
  • Itching or irritation at the vaginal opening
  • Discomfort during a pelvic exam or with a tampon
  • Urinary urgency, burning with urination, or repeat urinary tract infections

What is happening

Estrogen keeps the tissue of the vagina, vulva, urethra, and bladder neck thick, elastic, and well supplied with blood. When estrogen falls, that tissue gets thinner, less elastic, and drier. The vaginal walls lose the folds that let them stretch. Blood flow drops, so natural lubrication with arousal drops too. The pH rises and the mix of bacteria shifts away from the lactobacilli that normally dominate.

Because the urethra and the trigone of the bladder develop from the same embryonic tissue as the vagina, they thin along with it. That is why “vaginal” dryness so often comes packaged with urinary urgency, burning, and repeat infections. Clinicians stopped calling this vaginal atrophy and started calling it genitourinary syndrome of menopause precisely because the bladder part is not incidental.

Why this one does not go away on its own

Hot flashes usually fade after some years. GSM does not. It is a structural change that continues as long as estrogen stays low, and left alone it tends to progress. Surveys consistently find that about half of postmenopausal women have symptoms and only a minority are being treated — partly because it is not asked about, and partly because women assume it is simply what aging is.

It is not, and the gap matters. Untreated GSM ends sex lives, makes routine pelvic exams and cervical cancer screening painful, and drives a cycle of urinary infections that gets treated with antibiotic after antibiotic while the underlying cause goes untouched.

How we approach it

We ask directly, because most women will not raise it first. We ask what hurts, when it started, whether it is at the opening or deeper, whether lubricants help, and whether you also have urinary symptoms. An exam tells us whether the tissue looks atrophic, whether the pelvic floor muscles have tightened up in response to months of painful sex, and whether there is anything else going on — lichen sclerosus and other vulvar skin conditions cause similar symptoms and are treated completely differently.

For most women the plan is low-dose vaginal estrogen plus a moisturizer, with a lubricant for sex. If you cannot use estrogen, vaginal DHEA and oral ospemifene are alternatives with trial evidence. If the pelvic floor has learned to guard, physical therapy is added, because treating the tissue alone will not undo a muscle pattern.

We recheck at about 12 weeks. This is a treatment you stay on rather than finish.

How we treat it

  • Vaginal estrogen

    Evidence for Vaginal estrogen: Strong evidence

    Cream, tablet, insert, or ring. Treats the tissue directly with minimal systemic absorption. First-line when GSM is the main problem.

  • Non-hormonal options

    Evidence for Non-hormonal options: Moderate evidence

    Vaginal moisturizers used regularly, lubricants for sex, vaginal DHEA, and oral ospemifene when estrogen is not an option.

  • Pelvic floor and bladder care

    Evidence for Pelvic floor and bladder care: Moderate evidence

    When pain has caused the pelvic floor muscles to guard and tighten, physical therapy is part of the fix.

  • The same tissue change that causes dryness also makes repeat infections more likely.

  • Urgency and frequency are part of GSM, not a separate problem, for many women.

Common questions

Is vaginal estrogen safe?

Low-dose vaginal estrogen produces blood levels close to what is normal after menopause, because so little is absorbed. In late 2025 the FDA updated labeling on estrogen products and removed the class-wide boxed warning, including from low-dose vaginal products. We still review your personal history before prescribing.

I had breast cancer. Can I use anything?

Possibly. Non-hormonal moisturizers and lubricants are always reasonable first steps. Low-dose vaginal estrogen may be an option for some breast cancer survivors, and that decision is made together with your oncologist — particularly if you take an aromatase inhibitor. Systemic hormone therapy is generally not used after breast cancer.

Will lubricants be enough?

Lubricants help with friction during sex but do not change the tissue. A vaginal moisturizer used a few times a week does more, and some women do well with moisturizers alone. If dryness is moderate or severe, or if you also have urinary symptoms, treating the tissue works better.

How long before it works?

Most women notice improvement within 4 to 8 weeks, and full benefit takes about 12 weeks. If you stop, symptoms usually return within a few months, because the tissue change resumes. Most women who benefit stay on a maintenance dose.

Do you offer vaginal laser treatment?

No. We do not offer vaginal laser procedures. The evidence does not support them over sham treatment for GSM, and they are not covered by insurance.

Medically reviewed by PLACEHOLDER — Medical Director, MD · Reviewed · Updated
PLACEHOLDER: replace with the reviewing clinician before launch.

Ready to talk to someone who treats this every day?

Insurance-based visits across metro Atlanta. No membership, no cash-pay program, no obligation to start hormones.